Senior insider sale
Chief Scientific Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$1.22M
383.81K shares
What this filing means
SOFIA MICHAEL J. plans to sell 383.81K shares of ARBUTUS BIOPHARMA CORP valued at approximately $1.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/19/2025ACC: 0001959173-25-002158
Officer· Chief Scientific Officer
Since Jul 2018
383.81K
Shares to sell
$1.22M
Approx. market value
150K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Merger Acquisition
Cash/Check
9/26/2012
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/26/2012 | Merger Acquisition Cash/Check | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
12.64K
Market value
$39.8K
3/18/2025
—Completed
Units to sell
50K
Market value
$170.6K
3/14/2025
—Completed
Units to sell
4K
Market value
$13.6K
3/14/2025
—Completed
Units to sell
157.16K
Market value
$481.3K
3/11/2025
—Completed
Units to sell
10K
Market value
$33.6K
3/7/2025
Planned — Approximate Date
nasdaqPlanned
Units to sell
150K
Market value
$480.0K
3/19/2025
Total
Units
383.81K
Value
$1.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/18/2025 | 12.64K | $39.8K | — | Completed |
3/14/2025 | 50K | $170.6K | — | Completed |
3/14/2025 | 4K | $13.6K | — | Completed |
3/11/2025 | 157.16K | $481.3K | — | Completed |
3/7/2025 | 10K | $33.6K | — | Completed |
| Planned — Approximate Date | ||||
3/19/2025 | 150K | $480.0K | nasdaq | Planned |
| Total | 383.81K | $1.22M | ||